gastric cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Voluntary participation in clinical research; Fully understand and be informed of this study, and sign an informed consent form; Willing to follow and capable of completing all testing procedures; 2) Gender is not limited, and the age at the time of signing the informed consent form is = 18 years old and = 70 years old; 3) Pathological report confirmed gastric cancer; 4) The time from the end of the previous use of traditional Chinese medicine, traditional Chinese patent medicines and simple preparations and immunomodulator (such as thymosin, lentinan, interleukin-12, etc.) to the start of the study must be = 2 weeks.
Exclusion criteria
Exclusion criteria: Exclusion criteria: 1) Simultaneously suffering from other malignant tumors; 2) Lack of complete imaging and epidemiological investigation data; 3) Individuals with known active or suspected autoimmune diseases, except those who were in a stable state of the disease at the time of enrollment (do not require systemic immunosuppressive therapy); 4) Known history of abuse or drug use of psychotropic substances; 5) Patients with unclear consciousness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NAT10, SMYD2; | — |
Secondary
| Measure | Time frame |
|---|---|
| cis-H3, NE; | — |
Countries
China
Contacts
Heilongjiang provincial hospital